We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., May 9, 2024 -- Completed enrollment in bempikibart alopecia areata (AA) Phase 2...
Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer PR Newswire WALTHAM, Mass., April 3, 2024 WALTHAM, Mass., April 3, 2024 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 5.64 | 22.2397476341 | 25.36 | 32.88 | 24.17 | 28520 | 28.00724253 | CS |
4 | 7.24 | 30.4713804714 | 23.76 | 32.88 | 21.28 | 27783 | 26.70553116 | CS |
12 | 14.76 | 90.8866995074 | 16.24 | 32.88 | 15.07 | 40453 | 25.12062253 | CS |
26 | 14.76 | 90.8866995074 | 16.24 | 32.88 | 15.07 | 40453 | 25.12062253 | CS |
52 | 14.76 | 90.8866995074 | 16.24 | 32.88 | 15.07 | 40453 | 25.12062253 | CS |
156 | 14.76 | 90.8866995074 | 16.24 | 32.88 | 15.07 | 40453 | 25.12062253 | CS |
260 | 14.76 | 90.8866995074 | 16.24 | 32.88 | 15.07 | 40453 | 25.12062253 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions